EPCAM and neoplasm: More recently developed approaches have incorporated additional markers for CTC/DTC detection, including markers for the detection of tumor cells that have undergone EMT, and yielding improved sensitivity and the detection of EpCAM-negative subsets of CTC/DTCs (6, 40, 42).